Members of the Mexican cannabis sector have told CannIntelligence they are pessimistic about whether the framework to regulate the national medical cannabis industry will be implemented before 2024.
This is despite the presentation of a draft last year by the Health Ministry and the Federal Commission for the Protection Against Health Risks (Cofepris), and the 2017 congressional legalisation of medical cannabis for therapeutic uses.
...
Need help?
Contact a sales representative right now and don’t wait
“ Grey area over medical cannabis regime in Mexico leaves industry pessimistic ”
Buy report request information:
“ Grey area over medical cannabis regime in Mexico leaves industry pessimistic ”
Members of the Mexican cannabis sector have told CannIntelligence they are pessimistic about whether the framework to regulate the national medical cannabis industry will be implemented before 2024.
This is despite the presentation of a draft last year by the Health Ministry and the Federal Commission for the Protection Against Health Risks (Cofepris), and the 2017 congressional legalisation of medical cannabis for therapeutic uses.
Get access to premium content that is normally only available for subscribers. For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
LATEST ALERTS
